Advanced search
Add to list

SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Louwagie, Amber, et al. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” Belgian Society for Human Genetics, 19th Annual Meeting, Abstracts, 2019.
APA
Louwagie, A., Decaesteker, B., De Brouwer, S., Denecker, G., de Carvalho Nunes, C., Olexiouk, V., … Speleman, F. (2019). SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma. In Belgian Society for Human Genetics, 19th Annual meeting, Abstracts. Liège, Belgium.
Chicago author-date
Louwagie, Amber, Bieke Decaesteker, Sara De Brouwer, Geertrui Denecker, Carolina de Carvalho Nunes, Volodimir Olexiouk, Karen Verboom, et al. 2019. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” In Belgian Society for Human Genetics, 19th Annual Meeting, Abstracts.
Chicago author-date (all authors)
Louwagie, Amber, Bieke Decaesteker, Sara De Brouwer, Geertrui Denecker, Carolina de Carvalho Nunes, Volodimir Olexiouk, Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke, Elena Afanasyeva, Pauline Depuydt, Fanny De Vloed, Ellen Sanders, Suzanne Vanhauwaert, Liselot Mus, Carl Herrmann, Siebe Loontiens, Geneviève Laureys, Björn Menten, Nadine Van Roy, Jo Vandorpe, David Creytens, Christophe Van Neste, Kaat Durinck, Frank Westerman, Rogier Versteeg, Johan Van Nes, Jan Koster, Sara Ek, Katleen De Preter, and Franki Speleman. 2019. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” In Belgian Society for Human Genetics, 19th Annual Meeting, Abstracts.
Vancouver
1.
Louwagie A, Decaesteker B, De Brouwer S, Denecker G, de Carvalho Nunes C, Olexiouk V, et al. SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma. In: Belgian Society for Human Genetics, 19th Annual meeting, Abstracts. 2019.
IEEE
[1]
A. Louwagie et al., “SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma,” in Belgian Society for Human Genetics, 19th Annual meeting, Abstracts, Liège, Belgium, 2019.
@inproceedings{8630833,
  author       = {Louwagie, Amber and Decaesteker, Bieke and De Brouwer, Sara and Denecker, Geertrui and de Carvalho Nunes, Carolina and Olexiouk, Volodimir and Verboom, Karen and Gartlgruber, Moritz and Van Loocke, Wouter and Afanasyeva, Elena and Depuydt, Pauline and De Vloed, Fanny and Sanders, Ellen and Vanhauwaert, Suzanne and Mus, Liselot and Herrmann, Carl and Loontiens, Siebe and Laureys, Geneviève and Menten, Björn and Van Roy, Nadine and Vandorpe, Jo and Creytens, David and Van Neste, Christophe and Durinck, Kaat and Westerman, Frank and Versteeg, Rogier and Van Nes, Johan and Koster, Jan and Ek, Sara and De Preter, Katleen and Speleman, Franki},
  booktitle    = {Belgian Society for Human Genetics, 19th Annual meeting, Abstracts},
  language     = {eng},
  location     = {Liège, Belgium},
  title        = {SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma},
  year         = {2019},
}